Copyright
©The Author(s) 2020.
World J Diabetes. Feb 15, 2020; 11(2): 33-41
Published online Feb 15, 2020. doi: 10.4239/wjd.v11.i2.33
Published online Feb 15, 2020. doi: 10.4239/wjd.v11.i2.33
Ref. (number of patients) | Diabetes type | Diabetes duration, median (IQR) or mean ± SD in years | Criteria for renal impairment diagnosis | eGFR,mean ± SD (mL/min/1.73 m2) | Albuminuria, median (IQR) (units) | Creatinine, median (IQR) or mean ± SD (mg/dL) | Other related measurements |
Akbas et al[16] (n = 68) | Type 2 | Micro-albuminuric patients: 9 (0-30); Macro-albuminuric patients: 8.5 (1-29) | Presence of albuminuria (> 30 mg/g Cr) | Micro-albuminuric patients: 94 ± 29; Macro-albuminuric patients: 64 ± 44 | Micro-albuminuric patients: 74 (33-294) (mg/g Cr); Macro-albuminuric patients: 716 (312-1985) (mg/g Cr) | Micro-albuminuric patients: 0.75 | BMI (kg/m2): 30; Waist circumference (cm): 102; SBP (mmHg): 135 (90-210); DBP (mmHg): 78 (40-110) |
(0.5-2); Macro-albuminuric patients: 1.4 (0.4-3.5) | |||||||
Christensen et al[17] (n = 200) | Type 2 | 13 ± 7 | Presence of albuminuria (> 30 mg/g Cr) | 89 ± 17 | 102 (39-229) (mg/24 h) | 0.86 ± 0.2 | BMI (kg/m2): 32.6; SBP (mmHg): 130 ± 16; Cholesterol (mg/dL): 151; LDL (mg/dL): 73.4; HDL (mg/dL): 46.4 |
Darabian et al[18] (n = 9) | Type 1 | NR | Presence of albuminuria (> 30 mg/g Cr) or ESRD | NR | NR | NR | NR |
Do et al[19] (n = 1) | NR | NR | ESRD (peritoneal dialysis) | (End-stage renal failure) | NR | 9.13 | BMI (kg/m2): 29.6 |
Kerr et al[20] (n = 36) | NR | NR | CKD diagnosis according to National Kidney Foundation Criteria | NR | NR | NR | NR |
Tonbul et al[21] (n = 17) | NR | NR | ESRD (hemodialysis or peritoneal dialysis) | (End-stage renal failure) | NR | NR | BMI (kg/m2): 28.5; SBP (mmHg): 135 ± 27; DBP (mmHg): 80 ± 16; LDL (mg/dL): 120; HDL (mg/dL): 37; Triglycerides (mg/dL): 127 |
Turan et al[22] (n = 39) | NR | NR | ESRD (hemodialysis) | (End-stage renal failure) | NR | NR | NR |
Turan et al[23] (n = 82) | Type 2 | 12.7 ± 6.7 | Presence of micro-albuminuria (30-300 mg/g) | 80 ± 20 | 134 ± 83 (mg/g) | 0.91 ± 0.2 | BMI (kg/m2): 34.4 ± 6.2; SBP (mmHg): 135 ± 16; DBP (mmHg): 80.5 ± 11; LDL (mg/dL): 123 ± 35; HDL (mg/dL): 44 ± 10.6; Triglycerides (mg/dL): 211 |
- Citation: Kleinaki Z, Agouridis AP, Zafeiri M, Xanthos T, Tsioutis C. Epicardial adipose tissue deposition in patients with diabetes and renal impairment: Analysis of the literature. World J Diabetes 2020; 11(2): 33-41
- URL: https://www.wjgnet.com/1948-9358/full/v11/i2/33.htm
- DOI: https://dx.doi.org/10.4239/wjd.v11.i2.33